ORITAVANCIN DIPHOSPHATE vs OSILODROSTAT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORITAVANCIN DIPHOSPHATE vs OSILODROSTAT: Safety Overview
| Metric | ORITAVANCIN DIPHOSPHATE | OSILODROSTAT |
|---|---|---|
| Total FAERS Reports | 276 | 1,626 |
| Deaths Reported | 4 | 191 |
| Death Rate | 1.4% | 11.7% |
| Hospitalizations | 27 | 526 |
| Average Patient Age | 58.5 yrs | 56.3 yrs |
| % Female Patients | 39.2% | 70.8% |
| FDA Approval Date | Aug 6, 2014 | Mar 6, 2020 |
| Manufacturer | Melinta Therapeutics, LLC | Recordati Rare Diseases, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |